Literature DB >> 30380412

Differential Roles of IL-2 Signaling in Developing versus Mature Tregs.

Martin Y Fan1, Jun Siong Low2, Naoki Tanimine3, Kelsey K Finn1, Bhavana Priyadharshini3, Sharon K Germana3, Susan M Kaech4, Laurence A Turka5.   

Abstract

Although Foxp3+ regulatory T cells (Tregs) require interleukin-2 (IL-2) for their development, it has been unclear whether continuing IL-2 signals are needed to maintain lineage stability, survival, and suppressor function in mature Tregs. We generated mice in which CD25, the main ligand-binding subunit of the IL-2 receptor, can be inducibly deleted from Tregs after thymic development. In contrast to Treg development, we find that IL-2 is dispensable for maintaining lineage stability in mature Tregs. Although continuous IL-2 signaling is needed for long-term Treg survival, CD25-deleted Tregs may persist for several weeks in vivo using IL-7. We also observe defects in glycolytic metabolism and suppressor function following CD25 deletion. Thus, unlike developing Tregs in which the primary role of IL-2 is to initiate Foxp3 expression, mature Tregs require continuous IL-2 signaling to maintain survival and suppressor function, but not to maintain lineage stability.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD25; IL-15; IL-2; IL-7; regulatory T cell

Mesh:

Substances:

Year:  2018        PMID: 30380412      PMCID: PMC6289175          DOI: 10.1016/j.celrep.2018.10.002

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

1.  Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies.

Authors:  Hervé Luche; Odile Weber; Tata Nageswara Rao; Carmen Blum; Hans Jörg Fehling
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

2.  IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

Authors:  Matthew A Burchill; Jianying Yang; Christine Vogtenhuber; Bruce R Blazar; Michael A Farrar
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Rapid assessment of in vitro expanded human regulatory T cell function.

Authors:  Joyce J Ruitenberg; Christopher Boyce; Ravi Hingorani; Amy Putnam; Smita A Ghanekar
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

4.  Continuous T cell receptor signals maintain a functional regulatory T cell pool.

Authors:  J Christoph Vahl; Christoph Drees; Klaus Heger; Sylvia Heink; Julius C Fischer; Jelena Nedjic; Naganari Ohkura; Hiromasa Morikawa; Hendrik Poeck; Sonja Schallenberg; David Rieß; Marco Y Hein; Thorsten Buch; Bojan Polic; Anne Schönle; Robert Zeiser; Annette Schmitt-Gräff; Karsten Kretschmer; Ludger Klein; Thomas Korn; Shimon Sakaguchi; Marc Schmidt-Supprian
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

5.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

6.  IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels.

Authors:  Jana Raynor; Allyson Sholl; David R Plas; Philippe Bouillet; Claire A Chougnet; David A Hildeman
Journal:  Front Immunol       Date:  2013-06-24       Impact factor: 7.561

7.  High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells.

Authors:  Christopher S Raymond; Philippe Soriano
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

8.  Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue.

Authors:  Lydia Lynch; Xavier Michelet; Sai Zhang; Patrick J Brennan; Ashley Moseman; Chantel Lester; Gurdyal Besra; Emilie E Vomhof-Dekrey; Mike Tighe; Hui-Fern Koay; Dale I Godfrey; Elizabeth A Leadbetter; Derek B Sant'Angelo; Ulrich von Andrian; Michael B Brenner
Journal:  Nat Immunol       Date:  2014-12-01       Impact factor: 25.606

Review 9.  Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells.

Authors:  Martin Y Fan; Laurence A Turka
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

10.  Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

Authors:  Sylvain Fisson; Guillaume Darrasse-Jèze; Elena Litvinova; Franck Septier; David Klatzmann; Roland Liblau; Benoît L Salomon
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  40 in total

Review 1.  Modulation of regulatory T cell function and stability by co-inhibitory receptors.

Authors:  Liliana E Lucca; Margarita Dominguez-Villar
Journal:  Nat Rev Immunol       Date:  2020-04-08       Impact factor: 53.106

2.  Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.

Authors:  Erika T Hayes; Cassidy E Hagan; Liliane Khoryati; Marc A Gavin; Daniel J Campbell
Journal:  J Immunol       Date:  2020-10-14       Impact factor: 5.422

3.  NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation.

Authors:  Su-Ho Park; Sunyoung Ham; Arim Lee; Andreas Möller; Tae Sung Kim
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

4.  Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis.

Authors:  Miguel Chillón; Carmen Espejo; Ángel Edo; Laura Calvo-Barreiro; Herena Eixarch; Assumpció Bosch
Journal:  Neurotherapeutics       Date:  2022-07-28       Impact factor: 6.088

Review 5.  Maternal and fetal T cells in term pregnancy and preterm labor.

Authors:  Derek Miller; Meyer Gershater; Rebecca Slutsky; Roberto Romero; Nardhy Gomez-Lopez
Journal:  Cell Mol Immunol       Date:  2020-05-28       Impact factor: 11.530

Review 6.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

Review 7.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

8.  The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.

Authors:  Hilary R Keller; Hye Kyung Kim; Yuna Jo; Ronald E Gress; Changwan Hong; Jung-Hyun Park
Journal:  J Immunol       Date:  2020-05-11       Impact factor: 5.422

9.  Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.

Authors:  Scott Best; Vi Lam; Tingting Liu; Nur Bruss; Adam Kittai; Olga V Danilova; Susan Murray; Allison Berger; Nathan D Pennock; Evan F Lind; Alexey V Danilov
Journal:  Leukemia       Date:  2020-03-16       Impact factor: 11.528

10.  Immunoregulatory role of IL-2/STAT5/CD4+CD25+Foxp3 Treg pathway in the pathogenesis of chronic osteomyelitis.

Authors:  Qi-Fen Mao; Zui-Fei Shang-Guan; Hong-Lei Chen; Kai Huang
Journal:  Ann Transl Med       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.